Citol (Citalopram)

Quick links

Choose a section

Quick links to important sections

Advertisements

Citol (Citalopram)

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Citol (Citalopram)

Quick Facts

Property Description
Active ingredient Citalopram (as hydrobromide)
Form Tablet, Oral solution
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Supporting emotional balance and mood regulation
Origin Synthetic (chemically derived)

What Type of Medicine is Citol (Citalopram)?

Citol (Citalopram) is a synthetic, prescription-only antidepressant classified as a Selective Serotonin Reuptake Inhibitor (SSRI). As a psychotropic agent, its general purpose is to support the central nervous system in achieving emotional equilibrium and helping to alleviate persistent feelings of low mood or anxiety. Citalopram is recognized globally for its role in depression management; in fact, the WHO Model List of Essential Medicines includes Citalopram to treat depressive disorders.

Composition, Origin, and Available Forms of Citalopram

The medication contains the active ingredient, Citalopram hydrobromide, which is a synthetic compound derived from a bicyclic phthalane structure. This substance exists as a racemic compound, a mixture of two mirror-image molecules, where the therapeutic action is specific to the (S)-enantiomer. Citalopram is primarily administered via the oral route and is available in standardized pharmaceutical preparations including tablets and an oral solution. These multiple dosage forms ensure flexibility in administration, which is vital for patients requiring consistent adherence to treatment, particularly adults with varying swallowing capabilities.

High Selectivity: How Citalopram Differs from Other Antidepressants

Citalopram is distinguished by its high selectivity, focusing primarily on the neuronal reuptake of serotonin (5-HT), which is why it is identified as a highly selective inhibitor among the SSRIs. This targeted mechanism allows for the potentiation of serotonergic activity in the brain with only minimal effects on other monoamines, such as norepinephrine or dopamine. This high degree of focus is an inherent property of the molecule that supports a specialized approach to achieving a stabilized emotional state, clinically recognized for its focused action compared to older, less selective pharmacological classes.

Regulatory References

  1. NIH: Citalopram Information
Advertisements

What side effects are possible with Citol (Citalopram)?

Possible Side Effects and Safety Information

The safety profile of Citalopram is established through official regulatory review, identifying known adverse reactions and necessary precautions.

Frequency-Classified Adverse Reactions

Adverse effects are categorized by frequency, though the documented incidence can vary. Ejaculation disorder (primarily delayed ejaculation) is one of the most frequently reported adverse reactions, with an incidence often double that of placebo. Other commonly reported effects can include decreased sexual desire or ability and somnolence (sleepiness).

Serious and Clinically Significant Risks

Official regulatory documents highlight several serious or clinically significant risks that require caution:

  • Dose-Dependent QT Interval Prolongation: Citalopram can prolong the QT interval, which may lead to a serious heart rhythm abnormality called Torsade de Pointes and ventricular tachycardia. For this reason, the maximum recommended daily dose for most adults is 40 mg, and the maximum dose is restricted to 20 mg for patients over 60, those with liver impairment, and those taking certain other medications.
  • Suicidal Thoughts and Behavior: Use in children, adolescents, and young adults (up to age 24) is associated with an increased risk of suicidal thoughts and behavior compared to placebo.
  • Serotonin Syndrome: This condition may occur, particularly when Citalopram is combined with other serotonergic agents. It involves rapid changes in mental status, movement, and nervous system activity.
  • Hyponatremia: Low blood sodium levels have been documented, especially in older adults, sometimes associated with the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).
  • Abnormal Bleeding: The drug can increase the risk of bleeding or hemorrhage (e.g., gastrointestinal bleeding).
  • Activation of Mania/Hypomania: Use may lead to the sudden onset of a manic or hypomanic state in susceptible individuals.

Safety-Related Restrictions

Citalopram is contraindicated (should not be used) with Monoamine Oxidase Inhibitors (MAOIs) or with the drug pimozide. It is not recommended for patients with congenital long QT syndrome or other conditions that increase the risk of heart rhythm problems, such as uncompensated heart failure or recent acute myocardial infarction.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Citalopram describes manifestations ranging from mild to severe, affecting both the central nervous system and the cardiovascular system. Documented overdose presentations may include somnolence, sedation, tremors, vomiting, dizziness, confusion, and amnesia.


Documented Severe Outcomes and Required Actions

The most serious documented outcomes involve cardiac toxicity and neurological toxicities. Severe risks include QT interval prolongation and the potential for life-threatening arrhythmias such as Torsade de Pointes, ventricular tachycardia, convulsions (seizures), and coma. Overdose may also result in Serotonin Syndrome.


When to Seek Immediate Medical Help

Regulators mandate that patients seek immediate care or contact a healthcare professional immediately if symptoms such as an irregular heartbeat, shortness of breath, dizziness, or fainting (syncope) occur. Management of overdose is primarily symptomatic and supportive, and no specific antidote is known.


Monitoring and Risk Factors

Overdose management may require ECG monitoring and electrolyte monitoring. Patients with underlying heart conditions or existing hypokalemia (low potassium) or hypomagnesemia (low magnesium) are noted to be at increased risk for severe cardiac complications in an overdose situation.

Advertisements

Therapeutic Uses of Citol (Citalopram)

What Citol (Citalopram) Treats: Main Uses and Benefits

Citol (Citalopram) is applied in clinical settings that involve acute or unstable symptom patterns, providing support that contributes to easing the overall symptom load. The medication is commonly used to help with conditions characterized by periods of heightened symptoms, such as Major Depressive Disorder (MDD). It is also relevant for managing symptoms in other conditions like panic disorder, Generalized Anxiety Disorder (GAD), and Obsessive-Compulsive Disorder (OCD). This medication is relevant when supportive symptom management is appropriate, as it assists with maintaining functional stability across key domains.


Managing Persistent Low Mood and Depressive Episodes

Citol is commonly used across conditions presenting with acute episodes, such as MDD, and other conditions characterized by low mood, feelings of emptiness, and the loss of interest or pleasure (anhedonia). It is relevant in situations where symptoms interfere with daily functioning, offering symptomatic relief that may help patients cope more steadily with symptom fluctuations and is relevant in situations involving recurrent or episodic manifestations.


Relieving Pathological Anxiety and Panic Symptoms

The medication is used across domains where additional symptomatic support is needed for anxiety and fear. It helps address symptom clusters that may appear suddenly or intensify over time, such as episodes of sudden, intense fear (panic attacks) and chronic, excessive, uncontrollable worry. By assisting with the management of these distressing manifestations, it contributes to improved comfort during periods of heightened symptoms and provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Symptom Burden

Use Case Symptom Focus Core Benefit
Panic Disorder Frequency of acute fear attacks May assist with managing symptom intensity
MDD Persistent sadness and anhedonia Supports general well-being
OCD Intrusive thoughts and compulsions Assists with maintaining functional stability

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Citol (Citalopram)?

Citol (Citalopram) eligibility is defined by specific population rules established in official regulatory documents. The medication is approved only for use in adults (18 years and older). It is not approved for children and adolescents under 18 years of age.

Absolute Contraindications (Must Not Use): Use is strictly contraindicated if a patient is taking, or has taken within the last 14 days, a Monoamine Oxidase Inhibitor (MAOI). The medicine is also prohibited for patients taking Pimozide or those with a known hypersensitivity to Citalopram.

Populations with Restricted or Conditional Use: The maximum recommended dose is restricted to 20 mg once daily for specific populations, including older adults (60 years and over) and patients with hepatic (liver) impairment. Use is generally not recommended for individuals with underlying cardiac risks, such as known QT-interval prolongation or uncompensated heart failure, or for those with severely reduced renal (kidney) function.

Pregnancy and Lactation Status: Citalopram is excreted into human breast milk, requiring caution. Third-trimester use is associated with potential risks to the newborn.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify interactions with Citalopram into two major types: pharmacodynamic synergy and pharmacokinetic interference. These classifications impose formal restrictions on co-administration.

Contraindicated Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and Intravenous Methylene Blue, is strictly contraindicated due to the risk of Serotonin Syndrome. A mandatory 14-day separation period must be observed when switching between Citalopram and an MAOI. The concurrent use of Citalopram and Pimozide or other medicines known to prolong the QTc interval is also formally prohibited.

Exposure-Altering and Pharmacodynamic Interactions

Citalopram clearance relies on the hepatic enzymes CYP2C19 and CYP3A4. Co-administering potent CYP2C19 inhibitors (e.g., Cimetidine, Omeprazole) leads to increased systemic exposure of Citalopram. This pharmacokinetic effect mandates dose restrictions for patients with hepatic impairment, those over 60 years of age, and CYP2C19 poor metabolizers.

Pharmacodynamic interactions include an increased risk of bleeding when combined with drugs that interfere with hemostasis, such as NSAIDs and Warfarin. Combining Citalopram with other serotonergic agents (e.g., Triptans, Lithium, St. John's Wort) may increase serotonergic effects, and the use of alcohol is generally not recommended.

Advertisements

Mechanism of Action

Citol's action is to selectively modulate chemical signaling processes involving the neurotransmitter serotonin (5-HT) within the Central Nervous System (CNS). This action is rooted in two core, interlinked mechanisms that produce gradual, sustained changes in neural pathway activity.

Selective Inhibition of Serotonin Reuptake

The mechanism begins with the binding of Citalopram to the Serotonin Transporter (SERT) (SLC6A4), the protein responsible for clearing 5-HT from the synaptic cleft. By selectively blocking this reuptake process, the drug immediately increases the extracellular concentration of 5-HT, thereby intensifying and prolonging its signaling to neighboring nerve cells.

Time-Dependent Neural System Adaptation

The sustained elevation of synaptic 5-HT initiates a slower, adaptive cascade of physiological changes over several weeks. This duration is required for the secondary changes, such as the desensitization of certain 5-HT receptors, to fully manifest. This long-term adjustment leads to a sustained modulation and reorganization of neural circuitry through the upregulation of growth factors, such as Brain-Derived Neurotrophic Factor (BDNF), supporting neuronal plasticity.

Influence of Racemic Composition on SERT Interaction

Citalopram is a racemic mixture containing an active (S)-enantiomer and a less active (R)-enantiomer. The R-enantiomer interacts with an allosteric site on the SERT, effectively dampening the inhibitory action of the S-enantiomer. This intrinsic functional antagonism limits the inhibitory action of the S-enantiomer on the SERT target.

Advertisements

Dosage and Administration Information

Citol (Citalopram) is designed exclusively for oral administration, available as both tablets and an oral solution. The medicine is taken once daily and can be consumed either with or without food. For consistency throughout the treatment course, it should be administered at approximately the same time each day.

The standard administration for Major Depressive Disorder in most adults begins with an initial dose of 20 mg once daily. If needed, this dose may be adjusted upwards, typically in 20 mg increments, after a minimum interval of one week. The maximum recommended daily dose for the general adult population is 40 mg. For certain conditions, such as panic disorder, the initial dose may be lower at 10 mg daily for the first week.

Dosing requires adjustment for specific populations. The maximum recommended daily dose is restricted to 20 mg for older adults (age 60 and over) and for individuals with hepatic impairment. If a dose is missed, general instruction is to take it as soon as it is remembered, unless it is nearly time for the next dose. Treatment is a long-term protocol, and discontinuation must follow the principle of gradual dose reduction (tapering) rather than abrupt cessation.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Citol (Citalopram)

Evidence for use in Major Depressive Disorder (MDD)

The evidence base relies heavily on short-term Randomized Controlled Trials (RCTs) and systematic reviews that explored changes in depressive symptom severity over periods typically lasting up to 12 weeks. Researchers monitored the proportion of subjects achieving a study-defined response or remission. Findings related to symptom score reduction are described in the studies. However, evidence concerning the rates of remission has been reported as mixed or inconclusive across some published analyses.

Evidence for use in Anxiety and Obsessive-Compulsive Disorder

For Panic Disorder and Generalized Anxiety Disorder (GAD), short-term, placebo-controlled trials tracked outcomes describing episodic changes, such as the frequency of panic attacks and anxiety symptom severity in adult populations. Research describes patterns measured in these studies, including specific outcomes related to patient-reported discomfort. For Obsessive-Compulsive Disorder (OCD), research involved RCTs and pilot studies monitored symptom severity over intermediate durations (up to 24 weeks). Research describes that meeting study outcome criteria often required a longer defined time interval than for MDD.

Long-Term Research and Study Gaps

Most available research focuses on the acute treatment phase (8–12 weeks). Long-term studies and maintenance trials have been conducted in MDD to evaluate outcomes over extended periods, exploring patterns related to recurrence. However, long-term effects on maintaining remission for many indications are not fully established. Furthermore, the evidence base for adolescents is limited, and research findings for this group have been varied. Subgroup findings are uncertain for certain patient populations, meaning results apply only to the specific populations studied.

Key Studies & References

  1. The effect of citalopram in panic disorder (Randomized Controlled Trial)
  2. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial
  3. Medication for OCD (Clinical Consensus/Guidance on SSRI use and trial duration)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Citol (Citalopram) (FAQ)

Q: How long does it typically take for a person to notice the full effects of Citol?

The drug's plasma concentration is generally stable after about one week of daily dosing. While this level is necessary for effect, clinical studies monitoring symptom improvement for the drug typically track changes over periods lasting up to 12 weeks.

Q: Is it normal to feel more anxious or restless when first starting Citol?

Official documents state that agitation and anxiety are among the symptoms that may occur, particularly when treatment is first started or after a dose change. Some regulatory documents note that an initial increase in anxiety has been reported, and these temporary feelings may subside within the initial weeks.

Q: Does Citol commonly cause changes in body weight (gain or loss)?

Regulatory adverse reaction reports indicate that changes in body weight are a possibility. Official information includes both significant weight loss or weight gain, as well as a decrease or increase in appetite, as possible effects of the medication.

Q: Can Citol cause increased sweating or trouble sleeping (insomnia)?

Yes, common side effects explicitly reported in official regulatory documents include increased sweating, known medically as hyperhidrosis. Difficulty falling or staying asleep, referred to as insomnia, is also listed as a commonly reported effect.

Q: Are there any specific concerns about taking Citol and driving or operating machinery?

Official precautions state that the drug may cause drowsiness and affect a person's judgment, thinking, and movements. Patients should understand that official warnings caution against driving a car or operating any complex machinery until they know how this medication affects their own body and mental state.

Q: What are the warnings regarding the use of Citol in young adults and adolescents?

The FDA label includes a Boxed Warning that the drug can increase the risk of suicidal thoughts and behaviors. This risk is noted to be higher in children, adolescents, and young adults up to the age of 24, especially when compared to placebo.

Q: Does Citol have known interactions with common over-the-counter pain relievers (like ibuprofen or aspirin)?

Yes, official warnings state that nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin may interact with Citalopram. Combining these medications may increase the risk of abnormal bleeding.

Q: What kinds of herbal supplements or remedies should be avoided while taking Citol?

The use of the herbal product St. John's wort is listed in the official label as a product that may interact with Citalopram. This combination can potentially increase the risk of side effects related to high serotonin levels.

Q: Can Citol affect a person's ability to concentrate or focus?

Side effects listed in official documents may include problems with thinking, concentration, or memory. A decreased ability to concentrate is specifically noted as a potential adverse reaction.

Q: Is there any research evidence concerning the use of Citol during pregnancy?

Official guidance advises patients who become pregnant while taking the drug to contact their healthcare provider. A registry is maintained to monitor pregnancy outcomes in women exposed to the drug.

Q: Are there any known issues with taking Citol while breastfeeding?

Official regulatory studies have documented the drug's transfer into breast milk and its potential for harmful infant effects. Regulatory guidance suggests that an alternative medication should be considered, or breastfeeding should be discontinued while the medicine is in use.

Q: How quickly do common side effects usually go away after starting Citol?

Most common adverse effects are generally mild-to-moderate and tend to appear early in treatment. Official information indicates that these effects may often resolve within the first few weeks as the body adjusts to the medication.

Q: Can Citol be used to treat panic attacks or conditions other than depression?

While the drug is primarily indicated for Major Depressive Disorder, some international regulatory approvals specifically list it for the treatment of Panic Disorder. This may include panic attacks occurring with or without agoraphobia (fear of places where escape might be difficult).

Q: What is the usual recommended follow-up schedule when starting treatment with Citol?

Regulatory-derived guidelines emphasize the need for regular assessment of the patient, particularly within the first one to two weeks of starting treatment. Continuous monitoring for potential changes in mood or behavior is crucial, especially during the first few months and whenever the dose is changed.

Q: Does Citol affect blood sugar levels or pose a concern for people with diabetes?

Official warnings note that for patients with diabetes, treatment with an SSRI may alter glycaemic control (the regulation of blood sugar). This may result in blood sugar levels becoming either too low or too high, and official information indicates that dosage adjustments for diabetes medications may be necessary.

Q: Are there any known links between Citol use and vision or eye problems?

Yes, a serious eye-related risk highlighted in the official label is angle-closure glaucoma, an eye condition that can lead to vision loss. Abnormal vision is also reported as a less serious adverse reaction.

Q: What are the reasons why a patient might need to have an EKG (ECG) while taking Citol?

An ECG or EKG test may be necessary due to the drug's risk of dose-dependent QTc interval prolongation, which affects the heart's electrical rhythm. Monitoring is particularly important for patients with specific cardiac risk factors or those taking other QT-prolonging medications.

Q: Is the tiredness or drowsiness sometimes experienced with Citol temporary?

Drowsiness, or somnolence, is a common side effect of the drug. Official data indicates it is often experienced early in treatment and may decrease over the initial weeks as the body becomes used to the medication.

Q: Are there common withdrawal symptoms that may occur if Citol is stopped suddenly?

Official documents on discontinuation syndrome describe possible symptoms that may occur if the drug is stopped abruptly. These include dizziness, nausea, vomiting, sensory disturbances such as 'electric shock sensations,' anxiety, agitation, and fatigue.

Q: Is there a possibility of an allergic reaction to Citol and what are the signs?

A severe allergic reaction is a possibility, and the drug label lists specific signs that should prompt a patient to seek immediate medical attention. These include developing a rash or hives, swelling of the face, tongue, or throat, or experiencing difficulty breathing.

Q: Does Citol affect dental health, such as causing dry mouth or other issues?

Official regulatory summaries of adverse events list dry mouth as a commonly reported side effect. This condition can affect dental health over time.

Q: What are the facts about Citol and its effect on appetite in new users?

Official reports of adverse events note that changes in appetite are a common effect of the medication. These changes are often experienced early in the course of treatment.

Q: Are there official statements about Citol's use in combination with other mental health medications?

Official documents describe potential interactions with other serotonergic agents, such as Lithium, and emphasize caution. Co-administration should be carefully considered due to the increased risk of Serotonin Syndrome.

Q: Are there specific symptoms that warrant immediate medical attention while taking Citol?

Yes, official warnings list critical symptoms that should prompt a patient to seek immediate medical attention, such as signs of Serotonin Syndrome (fever, confusion, severe muscle stiffness), severe allergic reaction (swelling, difficulty breathing), or signs of heart problems (chest pain, fainting, or an irregular heartbeat).

Q: What is the half-life of Citol, and why is this important for steady-state concentration?

Citalopram has a mean terminal half-life of approximately 35 hours. This figure is important for understanding how long the drug stays in the body, as it indicates that steady-state plasma concentrations—the consistent level needed for full effect—are reached in about one week of daily dosing.

Q: Can Citol cause vivid dreams or changes in sleeping patterns?

The drug label includes reports of sleep disorder as an adverse reaction. This category can encompass various changes in sleeping patterns, including alterations in dream content.

Q: Is it common to yawn a lot when first starting Citol?

Yes, yawning is explicitly listed as a commonly reported side effect in official regulatory adverse event summaries for this medication.

Q: What are the reported effects of Citol on children or pediatric populations?

The drug is not approved by the FDA for use in children, and safety and efficacy have not been established in this population. Its use is associated with a risk of increased suicidal thoughts and behaviors in adolescents.

Q: Can Citol affect the ability to operate complex machinery, not just driving?

Yes, the official precautions state that patients should not operate machinery until they are aware of how the medication affects them, in addition to warnings about driving a car.

Advertisements

How should Citol (Citalopram) be stored and disposed of?

Storing and Disposing of Citol (Citalopram)


Citalopram must be stored at Controlled Room Temperature, which is specified as 20 C to 25 C (68 F to 77 F). The medication must be kept in the original container and maintained tightly closed to protect it from excess heat and moisture; storage in the bathroom is prohibited. The oral solution form may be stable for up to 16 weeks after opening when stored under these conditions.

All forms of Citalopram must be kept strictly out of the reach of children, including storage in a safe location that is up and away, with safety caps locked. For disposal of unused or expired product, official instructions recommend using a drug take-back program. If a take-back program is unavailable, the product should be mixed with an undesirable substance before being sealed and placed in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Citol (Citalopram) found in:

A-Z Index: